Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on LI 4. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105753864B reveals a novel Pd-Cu catalyzed synthesis for high-purity antitumor intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Novel LDA-free synthesis for Obeticholic Acid intermediates reduces cost and complexity. Scalable pharmaceutical intermediates manufacturing with high purity and supply reliability.
Novel patent CN108264532A details mild obeticholic acid synthesis reducing hazardous reagents. Enhances supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing globally.
Patent CN100534986C reveals a one-pot method using BTC and DMF, offering mild conditions and high purity for reliable pharmaceutical intermediates supply chains.
Patent CN116836214B details a plant-based synthesis route for 7-ketolithocholic acid intermediates, offering high purity and supply chain security for pharmaceutical manufacturing.
Novel one-step oxidation method for triiodobenzenetricarboxylic acid using KMnO4. High purity >98.5%, scalable process for contrast agent intermediates.
Patent CN110143881B reveals a novel thiourea dioxide method for separating nitro compounds in boscalid synthesis, offering significant cost reduction and purity improvements for agrochemical manufacturers.
Novel patent CN119504740A details a cost-effective Palbociclib synthesis. Enhances supply chain reliability and purity for pharmaceutical manufacturers.
Advanced synthesis of Prulifloxacin intermediates via novel bromomethyl-dioxolone route. Delivers >97.5% crude purity and scalable manufacturing for global supply chains.
Novel Suzuki-first synthesis route for Alzheimer's API intermediates. High yield, scalable process eliminating toxic CCl4 and chromatography.
Patent CN103396344B reveals a one-pot CDI method for Boceprevir intermediates, offering high purity, reduced toxicity, and scalable manufacturing for global supply chains.
Novel electrochemical NHK reaction reduces waste and time for Eribulin intermediate ERB manufacturing, offering cost-effective supply chain solutions.
Novel patent CN116444477B offers high-yield synthesis route. Reduces operational cost and improves supply chain reliability for global pharmaceutical intermediates manufacturing partners.
Discover the novel Cu-catalyzed synthesis of polysubstituted benzothiazoles from patent CN111187233B. Achieve cost reduction in API manufacturing with high atom economy.
Novel condensed ring liquid crystal compound patent CN110461852A offers high Tni and large dielectric anisotropy for advanced LCD manufacturing and supply chain optimization.
Novel single-atom Fe catalysis for 2-amidoquinoline. Green, efficient route for pharmaceutical intermediates. Cost-effective supply chain solution.
Patent CN111848680B reveals a novel bidentate ligand for high-efficiency asymmetric synthesis. Discover cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN103467270B details a safer ozonolysis route for 3-oxocyclobutanecarboxylic acid. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Patent CN110028448A reveals a copper-catalyzed synthesis route offering cost reduction and mild conditions for high-purity pharmaceutical intermediates manufacturing.
Patent CN114591369B discloses a spirocyclic phosphoramidite ligand enabling high enantioselectivity in palladium-catalyzed reactions, offering robust supply chain solutions.